Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jul;6(3):163-8.
doi: 10.2450/2008.0031-07.

Inhibitors in mild/moderate haemophilia A: two case reports and a literature review

Anna Chiara Giuffrida  1 , Sabrina Genesini, Massimo Franchini, Marzia De Gironcoli, Giuseppe Aprili, Giorgio Gandini
Affiliations
Review

Inhibitors in mild/moderate haemophilia A: two case reports and a literature review

Anna Chiara Giuffrida et al. Blood Transfus. 2008 Jul.
No abstract available

PubMed Disclaimer

References

    1. Brettler DB. Clinical aspects and therapy for haemophilia A. In: Hoffman R, Benz EJ, Shattil SJ, et al., editors. Hematology. Basic Principles and Practice. 2. Churchill Livingstone Inc; 1995. pp. 1648–63.
    1. Mannucci M. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years. Haemophilia. 2000;6 (Suppl 1):60–7. - PubMed
    1. Lethagen S. Desmopressin in mild haemophilia A: indications, limitations, efficacy and safety. Semin Thromb Hemost. 2003;29:101–6. - PubMed
    1. Hay CRM, Ludlam CA, Colvin BT, et al. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Thromb Haemost. 1998;79:762–6. - PubMed
    1. Peerlinck K, Jacquemin M. Characteristics of inhibitors in mild/moderate haemophilia A. Haemophilia. 2006;12 (Suppl 6):43–7. - PubMed